Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-036815
Filing Date
2010-07-06
Accepted
2010-07-06 21:10:49
Documents
1
Period of Report
2010-07-01

Document Format Files

Seq Description Document Type Size
1 form433537_070610211032-.html 4  
1 form433537_070610211032-.xml 4 4146
  Complete submission text file 0001144204-10-036815.txt   5925
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address DEUTSCHE BANK ASSET MANAGEMENT 6TH FLOOR 280 PARK AVENUE NEW YORK NY 10017
Business Address
SHIEBLER WILLIAM N (Reporting) CIK: 0001221432 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 10940849